Cathie Wood-led Ark Invest on Thursday expanded its stake in Teradyne Inc. (TER) while also adjusting positions in multiple other companies, including a significant reduction of stake in Palantir Technologies Inc. (PLTR).
The Teradyne Trade: Ark Invest’s most substantial move on Thursday was its investment in Teradyne Inc. (TER), purchasing a total of 172,037 shares across its ARKK, ARKQ, and ARKX ETFs.
At Thursday’s closing price of $115.08, this investment amounts to approximately $19.8 million.
Teradyne is an automatic test equipment that supplies to the likes of Qualcomm and Samsung.
The 10X Genomics Trade
Continuing its investment in the biotech sector, Ark Invest added more shares of 10X Genomics Inc. (TXG) to its portfolio.
On Thursday, Ark acquired a total of 369,826 shares across its ARKG and ARKK ETFs.
With TXG closing at $15.08, this transaction is valued at approximately $5.6 million.
Ark’s consistent investment in 10X Genomics underscores its belief in the company’s innovative approach to single-cell analysis, which is expected to drive significant advancements in personalized medicine.
Other Key Trades:
- Sold 127,969 shares of Palantir Technologies Inc. (PLTR), valued at around $10.4 million.
- Acquired 743,311 shares of Butterfly Network Inc. (BFLY), worth approximately $3 million.
- Sold 33,404 shares of Roblox Corp. (RBLX), totaling about $2.4 million.
- Sold 251,278 shares of Rocket Lab USA Inc. (RKLB), valued at roughly $7.2 million.
- Bought 8,304 shares of Qualcomm Inc. (QCOM), totaling approximately $1.4 million.
Planning your financial journey can be daunting but it doesn't have to be. Fire Fast by Dzambhala helps you understand and plan effectively.
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us.